IgM and IgG dosage

DIAGNOSTIC_TEST2 trials

Sponsors

Code Pharma

Conditions

COVID-19Covid19

Phase 1

Study of Codivir in Patients With COVID-19

CompletedNCT04930861

Code PharmaCovid19

Start: 2021-03-29End: 2021-08-09Updated: 2021-11-02

Phase 2

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

RecruitingNCT05218356

Code PharmaCOVID-19

Start: 2022-01-20End: 2025-07-20Target: 130Updated: 2024-10-02